TY - JOUR
T1 - Jordanian women's experience with etonogestrel subdermal contraceptive implant in two family planning clinics
AU - Al-Jefout, Moamar
AU - Nawaiseh, Nedal
AU - Tashman, Sahar
AU - Ryalat, Rawan
AU - Zaitoun, Sara
AU - Al-Alawi, Louai
AU - Tabaza, Wassem
N1 - Publisher Copyright:
© 2015 DAR Publishers/The University of Jordan. All Rights Reserved.
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Objective: Etonogestrel subdermal hormonal contraceptive implant (Implanon®) is a popular and effective contraceptive. However, some users discontinue it for a variety of reasons. To explore the experience of Jordanian women with Implanon. Methods: This survey was undertaken with 69 women who had used or were using Implanon. Data was obtained through telephone interviews and by examining the women's medical records. Results: The mean age of participants was 30.9 (± 4.99) years. All users had pre-insertion counseling by family planning nurses. No pregnancies occurred while on Implanon. At the time of the survey, 37 women had Implanon in situ and 32 women had Implanon removed due to side effects. Thus, the discontinuation rate was 46.4%. The main reason for discontinuation was bleeding problems. The other main reasons for removal were: weight gain (34.4%), mood change (50%), headache (34.4%), nausea (21.9%), reduced libido (40.6%), acne (15.6%) and hirsutism (3.1%). Of those who discontinued the implant (n=32), 20 women (40.8%) experienced a period duration of < 8 days compared to 12 women (60%) with periods > 8 days (Chi square 7.9, p value = 0.005). Moreover, 62% of current implant users reported higher satisfactory pre-insertion knowledge of the advantages and disadvantages than those who removed it (chi-square=5.12, p=0.024). Conclusions: The discontinuation rate of Implanon was rather high compared to other countries. The main reason for discontinuation was abnormal bleeding pattern. This is the first report about discontinuation rate of Implanon in Jordan.
AB - Objective: Etonogestrel subdermal hormonal contraceptive implant (Implanon®) is a popular and effective contraceptive. However, some users discontinue it for a variety of reasons. To explore the experience of Jordanian women with Implanon. Methods: This survey was undertaken with 69 women who had used or were using Implanon. Data was obtained through telephone interviews and by examining the women's medical records. Results: The mean age of participants was 30.9 (± 4.99) years. All users had pre-insertion counseling by family planning nurses. No pregnancies occurred while on Implanon. At the time of the survey, 37 women had Implanon in situ and 32 women had Implanon removed due to side effects. Thus, the discontinuation rate was 46.4%. The main reason for discontinuation was bleeding problems. The other main reasons for removal were: weight gain (34.4%), mood change (50%), headache (34.4%), nausea (21.9%), reduced libido (40.6%), acne (15.6%) and hirsutism (3.1%). Of those who discontinued the implant (n=32), 20 women (40.8%) experienced a period duration of < 8 days compared to 12 women (60%) with periods > 8 days (Chi square 7.9, p value = 0.005). Moreover, 62% of current implant users reported higher satisfactory pre-insertion knowledge of the advantages and disadvantages than those who removed it (chi-square=5.12, p=0.024). Conclusions: The discontinuation rate of Implanon was rather high compared to other countries. The main reason for discontinuation was abnormal bleeding pattern. This is the first report about discontinuation rate of Implanon in Jordan.
KW - Bleeding disturbances
KW - Decreased libido
KW - Discontinuation rates
KW - Etonogestrel releasing-subdermal implant
UR - http://www.scopus.com/inward/record.url?scp=84926344782&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926344782&partnerID=8YFLogxK
U2 - 10.12816/0025096
DO - 10.12816/0025096
M3 - Article
AN - SCOPUS:84926344782
SN - 0446-9283
VL - 49
SP - 27
EP - 35
JO - Jordan Medical Journal
JF - Jordan Medical Journal
IS - 1
ER -